Cellebration Life Sciences is a pre-clinical trial R&D company focused on a permanent curative treatment for Type 2 Diabetes through the use of Stem Cells.
| Website | https://cellebrationlifesciences.com/ |
| Employees | 6 (1 on RocketReach) |
| Founded | 2020 |
| Phone | +1 949-340-2647 |
| Industry | Hospitals and Health Care |
| Keywords | Stem Cells, Stem Cell Therapy, Type 2 Diabetes Treatment, Preclinical Trials, R&D, Diabetes Research, Regenerative Medicine, Stem Cell Research, Cell Therapy, Diabetes Cure, Medical Research, Pharmaceutical Research, Biotechnology, Drug Development, Clinical Trials, Life Sciences, Biomedical Research, Therapeutic Research |
| Competitors | Roche, Thermo Fisher Scientific, BD, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Myriad Genetics, KPL +33 more (view full list) |
Looking for a particular Cellebration Life Sciences employee's phone or email?
Timothy Kopatich is the CEO of Cellebration Life Sciences.
1 people are employed at Cellebration Life Sciences.